LinkBack URL
About LinkBacks
Women's Health Tips
Women's Health Info
Gynecology
Alcohol Consumption and the Ovaries
Heavy and chronic drinking can lead to inadequate functioning of the ovaries, resulting in hormonal deficiencies, sexual dysfunction, infertility, menstrual irregularities, and early menopause
-------------------------------------
Alternatives to Postmenopausal Hormones
All women can adopt a healthy lifestyle, such as not smoking, regular exercise, and good nutrition. In addition, other prescription drugs, such as statins or beta-blockers, are available to lower blood lipid levels or blood pressure levels. A healthy lifestyle can also help decrease a woman's risk of bone loss. In addition, health professionals also recommend calcium and vitamin D supplements as a means of preventing osteoporosis. Other drugs, such as raloxifene, tibolone, alendronate, and risedronate have been shown to prevent bone loss. These drugs increasingly are becoming the treatment of choice for osteoporosis in many postmenopausal women. The investigational drug PTH (parathyroid hormone) is another prevention approach being evaluated in clinical trials.
Counter PMS
Eat right to counter PMS symptoms.
Studies have shown that certain foods can help ease PMS symptoms. These include complex carbohydrates such as pasta, vegetables and whole grain breads and cereals. Avoid foods that contain caffeine -- cola, coffee and chocolate can all trigger PMS symptoms.
-----------------------Device to Treat Fibroids Wins Approval
The U.S. Food and Drug Administration has approved a medical device to shrink non-cancerous uterine fibroid tumors, sparing women from painful surgery to remove them.
The device, meant for women who no longer intend to become pregnant, could also save many from having to have hysterectomies, where the entire uterus is removed.
Made from a material called Embosphere Microspheres, the product is used in less invasive surgeries that involve uterine artery embolization (UAE), designed to block blood flow to the tumors and shrink them.
In clinical trials sponsored by the maker of the device, Biosphere Medical Inc., 132 women with uterine fibroids were treated at seven hospitals throughout the United States. After six months, 65 percent of women implanted had a 50 percent or more reduction in bleeding attributed to the fibroids.
As a condition of approval, the company is required to follow study participants for at least three more years to gauge the long-term effects of the treatment, including whether the fibroids tend to return, the FDA says.
------------------
Reply With Quote
Bookmarks